Your search returned 3 results.

Results
	1.	The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human Neuroblastoma. [electronic resource] by Lowery, Caitlin D VanWye, Alle B Dowless, Michele Blosser, Wayne Falcon, Beverly L Stewart, Julie Stephens, Jennifer Beckmann, Richard P Bence Lin, Aimee Stancato, Louis F Producer: 20180619 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors. [electronic resource] by Calvo, Emiliano Braiteh, Fadi Von Hoff, Daniel McWilliams, Robert Becerra, Carlos Galsky, Matthew D Jameson, Gayle Lin, Ji McKane, Scott Wickremsinhe, Enaksha R Hynes, Scott M Bence Lin, Aimee Hurt, Karla Richards, Donald Producer: 20170124 In: Oncology vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer. [electronic resource] by Wehler, Thomas Thomas, Michael Schumann, Christian Bosch-Barrera, Joaquim Viñolas Segarra, Nuria Dickgreber, Nicolas J Dalhoff, Klaus Sebastian, Martin Corral Jaime, Jesus Alonso, Miriam Hynes, Scott M Lin, Ji Hurt, Karla Bence Lin, Aimee Calvo, Emiliano Paz-Ares, Luis Producer: 20180326 In: Lung cancer (Amsterdam, Netherlands) vol. 108 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)